share_log

HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $6

HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $6

HC Wainwright & Co.维持对ADMA生物制剂的买入,将目标股价上调至6美元
Benzinga ·  01/09 07:09

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $5 to $6.

HC Wainwright & Co. 分析师拉古拉姆·塞尔瓦拉朱维持ADMA Biologics(纳斯达克股票代码:ADMA)的买入并将目标股价从5美元上调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发